Brainomix

About:

Brainomix specializes in the creation of AI-powered imaging biomarkers that enable precision medicine for better treatment decisions

Website: http://www.brainomix.com

Twitter/X: brainomix

Top Investors: Innovate UK, Tencent, Parkwalk Advisors, Oxford University Innovation, EASME - EU Executive Agency for SMEs

Description:

Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providing real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.

Total Funding Amount:

$35.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Oxford, Oxfordshire, United Kingdom

Founded Date:

2010-01-01

Contact Email:

info(AT)brainomix.com

Founders:

Andrew Barker, Michalis Papadakis

Number of Employees:

11-50

Last Funding Date:

2023-10-09

IPO Status:

Private

© 2024 MyAiNote.com